Literature DB >> 27390045

RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw.

Vittorio Fusco1, Giuseppina Campisi2, Gianmauro Numico2, Cesar A Migliorati2, Daniele Santini2, Alberto Bedogni2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27390045     DOI： 10.1093/jnci/djw155

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases.

Authors:  Francesco Erovigni; Alessio Gambino; Marco Cabras; Antonella Fasciolo; Silvio Diego Bianchi; Elisa Bellini; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2016-10-29

Review 2.  Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature.

Authors:  Kununya Pimolbutr; Stephen Porter; Stefano Fedele
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

3.  Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

Authors:  Giacomo Oteri; Giuseppina Campisi; Vera Panzarella; Ilaria Morreale; Riccardo Nucera; Olga Di Fede; Antonio Picone; Antonia Marcianò
Journal:  Biomed Res Int       Date:  2018-05-29       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.